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1. ABSTRACT 
An oronasal fistula is a passage between the oral and nasal cavity. Currently, surgical 
procedures use mucosal flaps or collagen grafts to make a barrier between oral and nasal 
cavities. Our aim was to develop a cell-free synthetic repair material for closure of nasal 
fistulas. We surface functionalized electrospun polyurethane (PU) and poly-L-lactic acid 
(PLLA) and composite polymer (PU-PLLA) membranes with acrylic acid through plasma 
polymerization. Membranes were treated in a layer-by-layer approach to develop highly 
charged electrostatic layer which could bind heparin as a pro-angiogenic glycosaminoglycan. 
The properties were evaluated through physical, chemical and mechanical characterization 
techniques. Cytotoxicity was tested with MC3T3 pre-osteoblast cell lines for 3, 7 and 14 days 
and vasculogenesis was assessed by implantation into the chorio-allantoic membrane in chick 
embryos for 7 days. In vivo biocompatibility was assessed by subcutaneous implantation in 
rats for 1, 3 and 6 weeks. The membranes consisted of random fibres of PLLA-PU with fibre 
diameters of 0.47µm and 0.12µm respectively.  Significantly higher cell proliferation and 
migration of MC3T3 cells at 3, 7 and 14 days were shown on plasma coated membranes 
compared to uncoated membranes. Further, it was found that plasma coated membranes were 
more angiogenic than controls. In vivo implantation of membranes in rats did not reveal any 
gross toxicity to the materials and wound healing was comparable to the native tissue repair 
(sham group). We therefore present a plasma functionalized electrospun composite polymer 
membrane for use in the treatment of fistulas. These membranes are flexible, non-cytotoxic 
and angiogenic and we hope should lead to permanent closure of oronasal fistula. 
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2. INTRODUCTION 
Congenital deformities of the lip and palate are very common with a prevalence of around 1 in 700 live 
births in the UK and USA and 1 in 500-700 worldwide (Mossey, 2004). Surgical intervention is almost 
always necessary to repair the soft and hard palate defects. Successful repair seeks to achieve complete 
separation of the oral and nasal cavities and this helps with acquisition of speech. However even after 
the most careful surgical procedures a persistent gap or hole sometimes appears between the two cavities 
termed a palatal fistula (Sadhu, 2009). Occasionally urgent repairs are needed with large sized fistula 
as these can lead to nasal emissions and leakage of fluid and food into the nasal cavity.  Fistulae are 
significantly higher in patients who have undergone repair of bilateral clefts of the lip and palate than 
for patients who have undergone repair of a unilateral cleft lip and palate (Hosseinabad et al., 2015). 
Additionally, palatal fistulae are more common in cases of combined cleft lip-cleft palate, compared to 
cleft palate alone (Hardwicke, Landini, & Richard, 2014). The most common location for a fistula is at 
the soft palate-hard palate junction (Bykowski, Naran, Winger, & Losee, 2015).  
There are a range of surgical techniques which have been developed to treat fistulae.  Their use will 
depend on the size of the fistula and its location and the cause of the defect. Depending on the type of 
surgical procedure performed the rate of fistula occurrence has been reported to be 4.9 % (Bykowski et 
al., 2015) or up to 17.7 % (Kahraman et al., 2014). These techniques range from the use of a pedicle 
buccal fat pad (BFP) (de Castro, de Souza, & Fernandes Santos, 2015); conchal cartilage graft to repair 
large fistula  [8]; multilayered repair of the whole palate (Funayama et al., 2014); or a tri-layered repair 
where the bone and cartilage are harvested from the nasal septum of the same patient and are used to 
create the middle layer sandwiched between two vascular layers (Hudson & Pickett, 2015).   
Acellular collagen grafts have been used in the 3-layer closure described above during a primary 
palatoplasty surgery. These are viewed as an effective and risk free strategy in preventing oronasal 
fistulation (Hudson & Pickett, 2015). Acellular dermal matrix allografts are also considered safe and 
effective for use in closure of large (more than 15 mm) and recurrent oronasal fistulae in the hard palate 
(Badami, Kreke, Thompson, Riffle, & Goldstein, 2006). However, cadaveric decellularised dermis is 
not universally available and as yet there are no well-established tissue banks in Pakistan.  Alloderm -
commercial donor dermis is available as an import item but extremely expensive and a patch of 7×5 cm 
is worth 100, 000 PK rupees (equivalent to 100 US dollars). 
Accordingly, our aim was to develop a synthetic biomaterial which could be used as an alternative to 
cadaveric skin or collagen grafts or patient’s tissues to assist in the closure of nasal fistulas.  There are 
a range of polymers routinely used for tissue guides because they are inherently biocompatible and one 
can choose their physiochemical properties and tailor them to the application required (Porter, Ruckh, 
& Popat, 2009).  Such polymers include Poly(-hydroxyl acid) related polymers, such as poly-L-lactic 
acid (PLLA) (Badami et al., 2006), poly glycolic acid (PGA) (Wang et al., 2012), poly-caprolactone 
(PCL) (Yoshimoto, Shin, Terai, & Vacanti, 2003) and their copolymers which have been extensively 
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studied for use in scaffold fabrication (Coombes & Meikle, 1994). Porous PCL-HA scaffolds 
(Chuenjitkuntaworn et al., 2010), poly (ε-caprolactone) coated in polydopamine (Zhang, Giese, Prukop, 
& Grunlan, 2011), poly (hydroxybutyrate) (PHB) and poly (hydroxybutyrate-co-hydroxyvalerate) 
(PHBV) (Sombatmankhong, Sanchavanakit, Pavasant, & Supaphol, 2007) are a few examples of such 
polymers.  
Additionally, polyurethanes (PUs) are very attractive because of their flexibility. They belong to a 
family of materials with a diversity of chemical compositions, mechanical properties, tissue-specific 
biocompatibility, and biodegradability (Zdrahala & Zdrahala, 1999). Their segmented block copolymer 
character endows them with a wide range of versatility in terms of tailoring their physical properties, 
blood and tissue compatibility making them attractive for both hard and soft tissue engineering (Alperin, 
Zandstra, & Woodhouse, 2005; Macocinschi, Filip, & Vlad, 2011). Their ability to distend and recoil 
without wear makes them attractive for pediatric applications like cleft palate repair and alveolar ridge 
augmentation, where materials with high tensile strength are required.  
Accordingly, we explored the potential of a PU electrospun membrane combined with PLLA to produce 
an elastic polymer composite to encourage cellular infiltration and matrix deposition and good in vivo 
tissue integration. Further we also explored a surface coating approach to bind heparin to the material 
to encourage rapid ingrowth of blood vessels and accelerate wound healing.  
3. Materials and methods 
3.1. MEMBRANE FABRICATION BY ELECTROSPINNING 
The cospun scaffolds were made by spinning the PU and PLLA from different syringes at the same 
time depositing both fibers on the rotating electrospun collector giving rise to intermingled membranes. 
PU Z3 (Biomer Technologies, Cheshire, UK) was dissolved in 70 / 30% dimethylformide: 
tetrahydrofuran (DMF: THF), respectively, in a concentration of 15% w/v. PLLA (Goodfellow, 
Cambridge, UK) was dissolved in dichloromethane (DCM) (Sigma-Aldrich, UK) in a 10% w/v ratio. 
The solutions were prepared at room temperature on a mechanical stirrer overnight. The following day, 
32 mL of PU solution was electrospun with a 50 mL syringe fitted with a multichannel needle holder, 
using 7 stainless steel blunt needles. It was placed horizontally on a programmable syringe pump (Kent 
Scientific, USA) with a discharge rate of 280 ul/min at 17 kV. For cospinning, 5ml PLLA was loaded 
in one 5 ml syringe on the right-hand side with a discharge rate of 40 ul/min. The syringe was supplied 
with 17 kV by a high voltage power supply (Genvolt, UK). The fibrous membrane was collected on a 
rotating drum 16 cm X 10 cm in diameter at a distance of 17 cm from the needle tips of both polymers. 
The rotation speed of drum was 300 rpm.  An 18 cm X 16 cm mat of approximately 150 µm thickness 
was formed. Membranes were produced at a room temperature of around 21.5°C. Single polymer mats 
of PU Z3 and PLLA were produce, as previously described [26, 28], for comparison of physical, 
chemical and mechanical properties. 
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3.2. A LAYER BY LAYER TREATMENT TO HEPARIN COAT THE MEMBRANES 
The electrospun PU, PLLA and cospun PU-PLLA membranes were initially plasma polymerized with 
polyacrylic acid and then treated in a layer by layer approach, finally being loaded with heparin ((Sigma-
Aldrich, USA) to enhance the ability of the membranes to promote angiogenesis. A layer-by-layer 
coating was achieved by building up layers of acrylic acid then polyethylenimine (PEI). The method of 
polymerization was as reported previously (Gigliobianco, Chong, & MacNeil, 2015). Briefly, first 98% 
polyacrylamide (Sigma-Aldrich, USA) in deionized water was used then the PU- PLLA mat was 
inserted into the glass chamber of the plasma rig. The initial pressure was adjusted at 3.0_10–2 mbar. 
The vacuum valve was then closed for 30 s and the final pressure was set at 4.2_10–1 mbar. The power 
was then switched on for 20 min by an RF-plasma at 13.56 MHz delivering at 15 W. Plasma 
polymerized electrospun membranes were transferred into an aqueous solution of 0.5% w/v PEI 
(Sigma-Aldrich, UK) at pH 9 for 30 min at room temperature. Membranes were washed four times with 
de- ionized water and they were immersed in a 100 U/mL aqueous solution of Heparin for 30 min at 
room temperature. Membranes were washed again four times with de ionized water and these steps 
were repeated each time to produce seven layers, with the last layer being PEI. After the layer-by-layer 
coating, membranes were dipped into 2 mL of 100 U/mL heparin aqueous solution for 4 h at room 
temperature. Afterwards, membranes were placed in fresh phosphate buffer saline (PBS) solution for 
24 h.  
3.3. SCANNING ELECTRON MICROSCOPY (SEM) 
After functionalization with PEI and heparin, PU, PLLA and PU-PLLA membranes were dried at room 
temperature. Samples were then gold coated using a sputter coater from Quorum Technologies. Samples 
were imaged using TESCAN Vega3 LMU scanning electron microscope (SEM) using ETD detector 
and SE mode. SEM images were acquired using an acceleration voltage of 15 kV with a beam intensity 
of 4 pA. 
3.4. FIBER THICKNESS AND PORE SIZE ANALYSIS OF PU-PLLA UNCOATED 
AND COATED MEMBRANE  
Fiber thickness was measured using Image-J software. Images at a magnification of 1000X were used 
for fiber thickness diameter. In the case of composite membranes, identification of each polymer was 
done based on the thickness and appearance of fibers (Gigliobianco et al., 2015), and 30 fibers from 
each polymer were measured. Separate membranes made of either PU or PLLA after being plasma 
coated or uncoated were analysed for fiber thickness and pore size and compared with cospun plasma 
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3.5. FOURIER TRANSFORM INFRARED SPECTROSCOPY ANALYSIS (FTIR) 
PU, PLLA and PU-PLLA membranes were characterized by Fourier transform infrared spectroscopy 
analysis (FTIR) (FTIR, Nicolet 6700, USA) by using photoacoustic mode. All spectra were collected 
with wave number ranging from 4,000 to 400 cm-1 at resolution of 8 cm-1 averaging 256 scans.  
3.6. ASSESSMENT OF HYDROPHOBICITY/HYDROPHILICITY OF MEMBRANES 
To measure the difference in the hydrophobicity or hydrophilicity of the membranes droplet image 
analysis was performed by directly measuring the contact angle (CA) from images of the droplet. This 
analysis was performed using a goniometer, which is usually composed of three parts: a background 
light, a sample stage and a camera.  A liquid droplet was carefully placed onto the surface of PU-
PLLA uncoated and coated membranes, an image of the droplet was captured and analyzed to 
determine a CA value. In this process, the background light, sample stage and camera were aligned to 
ensure accurate CA measurement.  
3.7. MECHANICAL PROPERTIES OF MEMBRANES 
Characterization of the biomechanical properties of the fabricated membranes was investigated by 
uniaxial tensile testing using a tensiometer (BOSE Electroforce test instruments, Minnesota, USA). To 
study the elastic properties, electrospun PU, PLLA and cospun PU-PLLA membranes were distended 
and relaxed for five cycles as shown in Figure 3 and then the ultimate tensile strength was assessed.  
Suture retention was also undertaken. Samples were cut keeping uniform width and length which were 
measured for each sample together with thickness, and then were clamped between two grips of 
tensiometer. The length between the clamps was kept uniform for all samples. A load cell of 45 N was 
used.  
For the tensile test, a ramp test was applied as previously mentioned [26]  at a rate of 0.1 mm/s and a 
displacement of 7mm (stress and strain were normalized by area and length of the sample respectively). 
Ultimate tensile strength was measured as the plateau at the first failure point. For the cyclic test, the 
material was stretched at a rate of 1mm/s and displacement was adjusted to 25% of its original length. 
Measurements were repeated at 5 cycles for each sample.  Plastic deformation was measured as the 
initial % of strain for each samples at the second cycle without an increase on stress due to this plastic 
deformation. Suture retention tests were also performed for each of the samples by taking a sample size 
of 1 x 0.5 cm. A non degradable suture was passed through the samples at a point approximately 0.25 
cm from the top edge at the mid point of the width. Each membrane was clamped so that the gap between 
the two grids was 0.75 cm. The data was obtained by plotting the max strength achieved before the 
suture ripped through the membrane as N. Porcine skin tissue was used as control for all tests. 
3.8. ASSESSMENT OF CELL COMPATIBILITY 
Cell culture on composite membranes was conducted using the mouse pre-osteoblast cell line (MC3T3 
ATCC® CRL-2593™). MC3T3 were expanded in Alpha minimum essential medium (αMEM) 
(Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine serum (FBS) (Sigma Aldrich 
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USA), 100 ug/mL of penicillin and streptomycin (Sigma Aldrich, Life Sciences USA). MC3T3s were 
expanded in culture flasks (Corning Biosystems). Cells were grown in a humidified incubator at 37°C 
with 5% CO2 with fresh media changes performed every 2–3 days. Cells were grown to 90% confluency 
and then detached using trypsin–EDTA (Sigma Aldrich, USA). MC3T3 cells were used between 
passages 4-7. To analyze the viability and proliferation of osteoblastic cells on PU-PLLA plama coated 
and non coated membranes, cells were seeded at a density of 50,000 cells per sample in 24 well plates, 
separate replicate plates were used for each time point. Prior to cell seeding, the membranes were 
sterilized with ethanol for 1 h, washed twice with PBS for 15 min. Cells cultured without membranes 
were used as controls. 
3.8.1. ALAMAR BLUE ASSAY 
In order to quantify cell viability and proliferation, fluorescent measurements of Alamar Blue were 
obtained after 3, 7 and 14 days. For each time point, cell seeded PU-PLLA membranes were carefully 
washed with PBS and 0.5 ml of 60ug/ml Alamar Blue solution (Sigma Aldrich, UK) (diluted with 
αMEM-FBS ) was added followed by incubation at 37°C for 3-4 h absorbance was measured at 570 nm 
using a fluorescence plate reader (Bio-TEK, NorthStar Scientific Ltd, UK). Alamar Blue is an 
oxidation– reduction (REDOX) indicator that both fluoresces and changes color in response to cellular 
metabolic activity.  Growth related reduction of the substrate causes the REDOX indicator to change 
from an oxidized (blue) form to a reduced (red) form. After the measurements were taken, samples were 
fixed for other studies. 
3.8.1. HISTOLOGY 
Histological samples were prepared from the cross section of unseeded and MC3T3-seeded membranes. 
Samples were fixed with 3.7% formaldehyde and washed 3 X PBS for 15 min each. They were then 
embedded in paraffin wax and 5 µm sections were obtained with a Leica Microtome, and stained for 
Hematoxylin and Eosin (H&E). Basically, the membranes were dehydrated in an ascending series of 
ethanol concentrations and then cleared in xylene for 3-4 min only, then the slides were stained with 
hematoxylin washed under running water and dehydrated with 50% alcohol and counter stained in eosin 
in 50% ethanol and then further dehydrated with absolute alcohol, cleared in xylene for 1 min. Slides 
were then covered with DPX (Sigma-Aldrich, USA) and a glass coverslip to be imaged with a light 
microscope (Motic, China). Samples were observed with a Leica optical microscope using Kohler 
illumination at 20X objective magnification and scaled at 100 µm. 
3.9. ASSESSMENT OF ANGIOGENIC PROPERTIES OF COATED MEMBRANES 
USING THE CHORIO-     ALLANTOIC MEMBRANE (CAM) ASSAY.  
Fertilized chicken (Gallus domesticus) eggs were purchased from VRI Lahore and incubated from day 
2 of fertilisation until day 8 at 37°C in a humidified egg incubator (HHD 435, China). At day 8, a square 
window (1 cm2) was cut into the shell and lifted, and a 1cm2 surface modified electrospun membrane 
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was placed onto the CAM. Half of the samples were fully functionalised prior to implantation, and then 
washed. The other samples were uncoated PU-PLLA membranes. Each egg was implanted with one 
membrane only. The shell window was replaced with parafilm (Bemis Flexible Packaging, USA) and 
sealed with adhesive tape. After implantation, eggs were placed again at 37°C in a 40% humidified 
incubator until day 14. At day 14, membranes were retrieved and the eggs were sacrificed.  
Angiogenesis was quantified by taking light microscope pictures just before membrane retrieval and 
blindly scored by four independent assessors using histological images of the retrieved membranes.  
3.9.1. HISTOLOGY OF CAM 
The membranes harvested from the CAM after 7 days of implantation were processed for histology. 
Membranes were fixed in 3.7% paraformaldehyde (Sigma Aldrich, USA) in PBS overnight. Next, they 
were processed either for cryo-sectioning or for paraffin embedding. The samples were placed into 
molds for cryo-sectioning filled with OCT solution (Leica, Germany). They were left to freeze at 80°C 
and 20 um sections were cut with a cryostat (Leica CM1860UV (Leica Germany)). Slides were then 
stained trichrome stain, according to the standard protocol for frozen slides (Ott et al., 2008). 
Quantification of cell infiltration and angiogenesis of each membrane after the CAM assay was based 
on the trichrome histology. For assessment of cell infiltration and angiogenesis, three independent 
assessors scored 20 images for cell infiltration and 12 images for angiogenesis.  The assessors did not 
know the nature of the samples they viewed.  The histology images were scored from 1 (no cell 
infiltration) to 3 (massive cell infiltration). Angiogenesis was assessed by counting the number of blood 
vessels per slide.  
3.9.2. SEM IMAGES OF IMPLANTS HARVESTED FROM CAM 
Harvested implants were fixed in 3.7% glutaraldehyde and dehydrated in a graded series of ethanol then 
transferred into t-butyl alcohol and dried. Samples were coated with gold and were examined under a 
scanning electron microscope.   
3.10. IN VIVO IMPLANTATION OF MEMBRANES 
The animal experiments were approved by the Animal Care and Use Committee of the University of 
Health Sciences, Lahore, Pakistan. Two samples were implanted in each male Wistar rat on each side 
of the back. 2 groups of samples were implanted—surface functionalized PU-PLLA membranes and 
plain PU-PLLA membranes and also one group of negative controls. Negative controls were sham 
operated rats and were not implanted with anything, only a surgical wound pocket was made and then 
closed by applying sutures just as in treatment groups. The implants were kept in place for either 1, 3 
or 6 weeks and 12 rats were used for each of the 3 groups (36 rats in total). Animals were placed in 
anesthetic; 100% isoflurane (Isoba) and kept under isoflurane anesthesia via a nose cone. A small area 
of skin at the back of the animal was shaved and disinfected, the skin was incised and flaps of the 
subcutaneous layer were raised (Figure 6aA-C). Implants were securely placed inside the created 
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pocket-like space with the help of fine forceps then subcutaneous layer and skin were closed with non- 
resorbable sutures. Animals were weaned from anesthesia and observed for recovery (Figure 6aD-E). 
3.10.1. ANIMAL SACRIFICE, SAMPLE FIXATION AND HISTOLOGY  
At weeks 1, 3 and 6 after implantation, 4 animals from each group were sacrificed using an overdose 
of anesthesia. Dorsal skin pieces of 2 cm2 containing implants at the underside were explanted (Figure 
6a F-G). Samples were fixed in 3.7% paraformaldehyde and paraffin embedded for histology. Sections 
of 6 µm thick were cut from the paraffin embedded samples with a microtome (Leica TP 1020 
Automatic Tissue Processor) and placed on Superfrost® plus slides (Menzel-Gläser, Denmark). 
Sections were processed for H&E staining, as above, for imaging. 
3.11.STATISTICAL ANALYSIS 
Unless stated otherwise, all experiments were conducted at least three times in triplicate. All data 
presented refer to standard error of the mean ± (sem). In order to check for any statistically significant 
differences, a one-way ANOVA or students t test was performed, multiple comparison post hoc test 
was done where needed. Results with p-values of < 0.001  were considered statistically significant. All 
data were analyzed using Graphpad Prism 7.0 software. 
4. Results 
4.1. MORPHOLOGICAL CHARACTERIZATION 
SEM of PU-PLLA co-spun membranes showed randomly oriented fibers with a mixture of thin and 
thick fibers (Figure 1A). Fiber thickness analysis revealed that there were two distinct populations of 
fibers some thicker and other thinner ones when measured through image J software (Figure 1A).  Fibre 
thickness was analysed from electrospun PU fibers and PLLA membranes separately and compared to 
cospun PU-PLLA fibres.  PU fibres were thin with an average thickness of 0.2 µm and PLLA fibres 
were thicker with an average thickness of 0.5µm. Students’ T test revealed that the difference between 
the means of PU and PLLA fibers was significant with 95 % CI of diff. with a p value of <0.0001. 
Plasma coating affected the thickness of PU-PLLA cospun fibers and differences between the thickness 
of fibers between PU-PLLA cospun uncoated and coated were significant (Figure 1A). The mean 
thickness of uncoated PLLA fibers was 0.112 µm and coated PLLA fibers was 0.169 µm whereas the 
mean thickness of uncoated PU fibers was 0.417 µm and coated PU fibers was 0.474 µm Figure 1B. 
One way ANOVA analyses of the samples suggested that the differences between uncoated and plasma 
coated samples were significant with a P value of <0.0001. Multiple comparisons post hoc test also 
suggested significant differences between the means of PU uncoated vs PU coated fibers and PLLA 
uncoated vs PLLA coated fibers. Pore size was measured to be 5.715 ± 0.4002 µm in uncoated and 4.09 
± 0.3043 µm in plasma coated samples. The pore size was significantly higher in uncoated membranes 
(results not shown). 
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Surface morphology analysis to evaluate hydrophobicity / hydrophilicity after before and after plasma 
coating included CA measurement which describes the behavior of a liquid droplet on a solid surface 
in air, and is defined as the angle between the tangent at the three phase point and the solid surface. The 
left and right contact angle of water droplet on the surface of PU-PLLA uncoated membrane was 
measured as 99.6° and 97.5° respectively (Figure 1B) and that of PU-PLLA coated membrane was 63.1° 
and 58.7° respectively (Figure 1B).    
 
4.2. CHEMICAL CHARACTERIZATION 
FTIR was used to identify the chemical structural characterization of the cospun PU-PLLA membranes. 
The representative FTIR spectra of PU and of PLLA are shown in Figure 2A, and the combined spectra 
of PU–PLLA (uncoated and coated) membranes are presented in Figure 2B. 
For PU (Z3), as shown in Figure 2A and B, the peak at 3325 cm−1, which indicates the N-H group in 
urethane (–NHCOO-), is attributed to the stretching v(N–H). The peak at 3124 cm-1 was the overtone 
of 1532 cm-1 and attributed to the v(C–H) in benzene ring of aromatic PU.  
The peaks at 2932 and 2856 cm-1 belong to the asymmetric and symmetric vibration of -CH2 of the 
polyether of Z3 and PLLA. The carbonyl absorption region was observed in between 1760 and 1704 
cm-1, the carbonyl absorption band classified into two peaks. The peak due to bonded C=O stretching 
was at 1704 cm-1 and the characteristic absorption bands at 1760 cm-1 and 2920 cm-1 are attributed to 
the stretching vibrations of the C=O and CH group of PLLA, respectively. 
The peak at ∼1194 cm-1, attributed to C-O-C asymmetric vibrations linked with asymmetric CH3 
rocking vibrations, in the region (1300-1000 cm-1), which is mainly related to the C-O-C stretching in 
PLLA.  
The peak at 1595 cm-1 was assigned to v(C=C) in the benzene ring and the 1419 cm-1 attributed to the 
strong v(C–C) in benzene ring.  Appearance of absorption band at 1310 cm-1 was assigned to amide III 
δ(N–H) + ν (C=N), and β(C–H) peak 1221 cm-1. The region between 1103 and 916 cm-1 was the ν(CH2–
O–CH2) of ether peak and 1018 cm-1 was the weak β(C–H) in benzene ring. At the same time heparin 
has four major absorption bands between 900 and 1700 cm-1, with one band made of two shoulders at 
969 and 1017 cm-1, and three bands at 1221, 1419, and 1604 cm which confirms its presence in cospun 
PU-PLLA membranes as depicted in Figure 2B. 
The FTIR results showed that no chemical reactions occurred between PLLA and PU during 
electrospinning as no new chemical bonds were identified 
However, this FTIR analysis could not detect the presence or absence of heparin on these membranes 
due to overlapping peaks positions as shown in Figure 2B. 
4.6. MECHANICAL PROPERTIES 
PLLA membranes showed the highest plastic deformation compared to PU and cospun PU-PLLA 
membranes, while last two membranes presented a very similar elastic behavior (Figure 3A and 3B). In 
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terms of tensile strength, the cospun-PU-PLLA membrane was significantly higher compared to PLLA 
and Z3 membranes and above the values of porcine dermis used as a reference commercial material 
clinically used for grafting of oral soft tissue defects (Herford, Akin, Cicciu, Maiorana, & Boyne, 2010) 
; while the last two membranes were between the range of values for porcine dermis (Figure 3C).  
All membranes were tested for their ability to retain sutures and there were no significant differences 
between them (Figure 3D).  
4.4. CULTURE OF CELLS ON SCAFFOLDS 
Figure 4A shows the viability of cells on the uncoated membranes as assessed using Alamar Blue. It 
was observed that the uncoated membrane showed similar cell viability and proliferation on tissue 
culture plastic (TCP) (Figure 4A). There was no significant difference between the TCP grown cells 
and those grown on uncoated membranes during the time period studied. However, the plasma coating 
positively affected the growth and viability of cells seeded on the membranes and showed significantly 
higher cell viability and proliferation compared to TCP control (Figure 4A).  
The appearance of the cells on the scaffolds is also shown In Figure 4B where cells and scaffolds are 
imaged by SEM and by staining with Hematoxylin and Eosin. This shows good attachment of cells to 
the scaffolds and H&E shows that they have spread out on the scaffolds and appear securely attached. 
This was the case for both uncoated and coated scaffolds. 
4.5. EFFECT OF HEPARIN BINDING ON ANGIOGENIC ACTIVITY OF MEMBRANES 
The angiogenic potential of the membranes was assessed through use of the CAM assay. Blood vessels 
can be seen growing towards the plasma coated membranes (Figure 5B and D). The cell infiltration was 
similar for the coated and uncoated membranes and no significant difference was observed; however, 
the number of blood vessels for the coated membranes was significantly higher compared to the 
uncoated controls (Figure 5).  
4.6. EVALUATION OF MATERIALS IN ANIMALS 
Plasma coated membranes loaded with heparin and uncoated membranes were implanted 
subcutaneously for three time periods, 1 week, 3 weeks and 6 weeks (Figure 6A-G). It was noted that 
the wounds healing was completed by skin closure and there was no scarring or inflammation when 
observed visually (Figure 6B). There were no signs of redness and swelling after 1 week (Figure 6B 
and C). The tissue was harvested and on opening of the subcutaneous tissue no signs of inflammation 
were observed at any time point (Figure 6C). After 3 weeks the wounds had healed completely and 
there was no scar formation with normal hair growth which covered the shaved area. To expose the 
implant, the hair was removed again and the skin was excised to completely remove the implanted 
membranes with the surrounding tissue (Figure 6D). The implants looked well embedded and could be 
clearly seen through the transparent subcutaneous layer (Figure 6E). At week 6 the implant site was 
completely indistinguishable from the rest of the body and the area was exposed by removing hair and 
implant was again clearly visible from the underside of the excised skin (Figure 6F and G).  
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4.6.1. HISTOLOGY OF IMPLANTS IN THE SUBCUTANEOUS TISSUE 
The implants were harvested from the rats and were fixed and processed for histology. The cross 
sections through the implants inside the subcutaneous tissue were stained with Hematoxylin and eosin 
and these confirmed that the tissue had integrated well into the skin layers (Figure 6H-P) with similar 
results for both coated (coated) and non-coated (not shown) membranes. It was noted that the implanted 
membranes were loosely embedded in the connective tissue under the skin. Six weeks after 
implantation. 
5. DISCUSSION  
Our aim in this study was to develop a membrane which would be useful for the surgical treatment of 
oronasal fistulae. To achieve this, we co-spun PU and PLLA to create mechanically flexible PU fibers 
interwoven with highly biocompatible PLLA. The porous nature of the membrane created by 
electrospinning encouraged cells to attach and proliferate and the membranes integrate well post-
implantation in rat tissue. We also surface modified these electrospun membranes to enhance their 
ability to stimulate new blood vessels ingrowth into the membranes.  
Any material designed to replace tissues for medical applications needs to have mechanical properties 
which can match the matrix of the host tissues without inducing any inflammation or toxicity. Also it 
needs to be easily processed and sterilized with an adequate shelf life (Macocinschi et al., 2011). PUs 
are elastomers with good biocompatibility. PU was chosen as a material that has been used extensively 
in medical devices and is capable of distension without distorting the surrounding tissues. Thus PUs 
have been used in clinical studies as implants and biomedical devices, vascular prosthesis, blood pumps, 
mammary prosthesis, heart valves, pace makers, intra-aortic balloons, catheters and artificial hearts 
(Baumgartner, Yang, & Cooper, 1997; Hung, Wu, Chien, & Hsu, 2009; Reddy, Kano, Maruyama, 
Hadano, & Takahara, 2008; Wu et al., 2009). Many of these fistulae occur in young children who grow 
fast and need highly distensible materials as devices.  
A combination of hydrophilic and hydrophobic properties increases the biocompatibility and hemo 
compatibility of PUs. Generally, solid surfaces with CAs less than 90° are considered hydrophilic, while 
surfaces with CAs higher than 90° are considered hydrophobic. The boundary between hydrophilicity 
and hydrophobicity for a smooth solid surface actually occurs at a CA of 65° (Patel, Varilly, & 
Chandler, 2010; Yoon, Flinn, & Rabinovich, 1997). Plasma surface coated membranes has left and right 
contact angles of 63.1° and 58.7° well below 65° which is an evidence of increased hydrophilic nature 
of the surface.  Fiber diameter was significantly higher after plasma coating and proportional to the pore 
size reduction after plasma coating as discussed in the results section. The combination of fiber 
thickness and void /pore size in these membranes was optimal with around 4-5.5 um void size (Lowery, 
Datta, & Rutledge, 2010) demonstrating good cell attachment and proliferation.  
Additionally, all membranes were easy to handle with a suture retention strength that makes them 
suitable for their surgical implantation into the oral mucosal layers of the palate (Hudson & Pickett, 
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2015).  The PU-PLLA membrane showed an elastic behavior which is desirable to cope with the 
physical distention of the oral mucosa, due to the elastomeric properties of PU. If these materials can 
stretch readily to accommodate the growth of the child, then they will be less likely to hinder or restrain 
facial development which is known to occur with bone implants which become fused in place leading 
to distortion of the growing face (Guerrero, 2012). The combination of the two polymers increased the 
tensile strength of the cospun membrane above the values of a commercial porcine tissue. In addition, 
the most relevant mechanical properties will need to be studied in vivo, which will be determined by 
the degradation rate of PLLA versus the production of new matrix. Therefore, due to an initial 
hydrolysis of PLLA after implantation, a higher tensile strength may be desirable to maintain the load-
bearing properties while cells infiltrate, and new matrix is produced. 
The fabricated membranes were modified by surface plasma polymerization showing heparin binding 
and promoting vascularization. The main problem in many implanted membranes is a lack of 
vascularization. Heparin and VEGF are some of many compounds used to enhance neo vascularization 
in membranes. Natural and synthetic heparin are more translatable compared to the much more 
expansive and less available recombinant growth factors. One of the many current techniques for 
surface functionalization is a layer by layer approach (Gigliobianco et al., 2015). In this technique 
alternative layers of PEI and heparin are built (Easton, Bullock, Gigliobianco, McArthur, & MacNeil, 
2014) and then we used the chick CAM to demonstrate that the coated materials were angiogenic.  
We confirmed through histology that more extensive infiltration of chick cells took place into the 
plasma coated membrane compared to the uncoated PU-PLLA membrane. In our studies plasma coated 
PU-PLLA membranes showed twice as much neovascularization as uncoated membrane within 7 days 
after implantation into the CAM assay.  
In addition, these fibrous polymer membranes were highly biocompatible promoting cell attachment 
and proliferation, and we further confirmed cell infiltration into the membranes through hematoxylin 
and eosin staining. In vivo implantation of these membranes in rat sub-cutaneous tissue also 
demonstrated good integration into the body. The animals did not show any signs of discomfort or any 
behavioral abnormality throughout the period of observation. Wounds healed with completely closure 
with no scar formation and a normal growth of hair by week 3. Histological sections of implants with 
surrounding tissue showed results consistent with the visual observation of the implant area in rats. The 
sections showed growing hair follicles with normal epidermis, dermis and implanted membrane 
infiltrated with cells. The dermis also showed dermal appendages and sebaceous glands as for the 
control sham operated skin tissue. 
A limitation of this study was the animal model selected, since the rats selected present a good wound 
healing (native tissue repair) and no differences were observed in that process when the coated or 
uncoated composite membranes were implanted. This model demonstrated initial safety and biocompatibility 
of the membranes produced.  Future studies should ideally involve more functional animal models- such 
as diabetic animals where wound healing is slow, and in particular implantation into a physiologically 
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relevant animal model of cleft palate such as the non-syndromic cleft palate mouse (Wnt9b−/clf1) 
(Juriloff & Harris, 2008) . 
 
Conclusions 
In conclusion, the production of a composite electrospun porous membrane which is surface modified 
results in a distensible material which can promote angiogenesis and is well tolerated when implanted 
in animals. We conclude that this material should be considered for further development as a promising 
approach for the surgical treatment of oral nasal fistulas. 
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Figure 1A. Top: Scanning Electron Micrographs of membranes. A. Uncoated PU- PLLA cospun 
membrane. B Plasma coated PU- PLLA cospun membrane. Bottom: Fiber thickness analysis of PU 
plain membrane, PLLA plain membrane, uncoated and plasma coated cospun membranes assessed by 
image J software. Oneway ANOVA multiple comparisons test (Sidak's multiple comparisons test) 
(*** statistically significant difference between each group, P value 0.0001). Figure 1B 
Hydrophobicity and hydrophilicity of (a) PU PLA Uncoated and (b) Coated membranes measured 
through contact angle analysis. 
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Figure 2. (A) Combined FTIR spectra of PLLA, and PU on common scale, (B) Combined FTIR of 
PU-PLLA cospun membranes and PU-PLLA coated with heparin. 
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Figure 3. Mechanical properties of PU-PLLA cospun membranes in comparison with plain PLLA and 
PU electrospun membranes. (A) Stress-strain curves of the cyclic test. (B) Plastic deformation. (C) 
Ultimate tensile strength in N/mm2 (*p<0.05). (D) Suture retention test. 
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Figure 4a. MC 3T3 cell viability assay on coated and non-coated membranes. Day 3, 7 and 14 (black 
bars) compared to controls TCP (white bars). Error bars represent standard error of the mean (n=3, 
*p<0.01) ns: not significant. 
Figure 4b. Top: Scanning electron micrographs of MC3T3 cells cultured on electrospun PU-PLLA 
membranes for 3 days. (A) Cells on coated PU-PLLA membrane. (B) Cells on uncoated fibrous 
electrospun membrane Bottom: Whole mount H&E images of PU-PLLA membranes 3 days after cell 
culture with MC3T3 cells. (C) Plasma coated membranes with nuclei stained in blue. (D) Uncoated 
cospun membranes with cells. Scale bar=100µm from Figure A to F. 
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Figure 5a. Chorio allantoic membrane assay (CAM) for vascularization, in chick embryo model. (A) 
Uncoated PU-PLLA membrane showing normal vascularization with no blood vessel growth towards 
the membrane, (B) Plasma coated PU_PLLA membrane after 7 days of implantation, blood vessels 
converging towards the membrane indicating neovascularization. (C) Histology of uncoated 
membrane after 7 days of implantation. (D) Plasma coated membrane with neovascularization (arrows 
showing small blood vessels BV). 
Figure 5b. Bar graph showing statistical analysis of cell infiltration scoring between categories 1-3 in 
uncoated and coated membranes (left), and total number of blood vessels on coated and uncoated 
membranes (right); ns: not significant, *** P value < 0.0001. 
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Figure 6a.  Method of in vivo implantation of plasma coated and uncoated membranes in rats. Figure 
6A-G whole mount images of surgical site. (A) Implantation site. (B) Healed wound after 1 week with 
no hair regrowth. (C) Harvesting of implant with surrounding skin at 1 week. (D) Implant site at 3 
weeks with hair growth. (E) Implant embedded in the subcutaneous tissue after 3 weeks. (F) Implant 
site after 6 weeks of surgical implantation, with hair shaved off. (G) Harvesting of implant from the 
skin after 6 weeks. 
Figure 6b. Histology of implanted membrane at different time points (H&E staining), all coated 
membranes were loaded with heparin pre-implantation. (H-J) Histology of skin after 1 week. (H) 
Sham operated (I) Morphology of skin after 1 week of implantation of uncoated membrane. (J) Skin 
implanted with plasma coated membrane. (K-M) 3 weeks after implantation. (K) Sham operated. (L) 
Skin with uncoated membrane. (M) Coated membrane implanted for 3 weeks. (N-P) 6 weeks after 
implantation of membrane. (N) Sham operated. (O) Uncoated Membrane implant. (P) Coated 
membrane after 6 weeks of implantation. Epi (epidermis), d (dermis), a (appendages), scaff, 
(Scaffold/membrane). Scale bar 100µm and 500µm. 
